Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: Q4Q6Z0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 63 | 65 | PF00675 | 0.261 |
CLV_PCSK_KEX2_1 | 15 | 17 | PF00082 | 0.477 |
CLV_PCSK_KEX2_1 | 61 | 63 | PF00082 | 0.245 |
CLV_PCSK_PC1ET2_1 | 15 | 17 | PF00082 | 0.463 |
CLV_PCSK_PC1ET2_1 | 61 | 63 | PF00082 | 0.242 |
CLV_PCSK_PC7_1 | 58 | 64 | PF00082 | 0.261 |
CLV_PCSK_SKI1_1 | 58 | 62 | PF00082 | 0.256 |
DEG_SCF_TRCP1_1 | 94 | 99 | PF00400 | 0.585 |
DOC_MAPK_gen_1 | 15 | 22 | PF00069 | 0.329 |
DOC_MAPK_RevD_3 | 49 | 64 | PF00069 | 0.474 |
DOC_USP7_MATH_1 | 112 | 116 | PF00917 | 0.553 |
DOC_USP7_MATH_1 | 123 | 127 | PF00917 | 0.467 |
DOC_USP7_MATH_1 | 4 | 8 | PF00917 | 0.581 |
LIG_14-3-3_CanoR_1 | 110 | 120 | PF00244 | 0.530 |
LIG_14-3-3_CanoR_1 | 25 | 31 | PF00244 | 0.484 |
LIG_14-3-3_CanoR_1 | 39 | 44 | PF00244 | 0.461 |
LIG_14-3-3_CanoR_1 | 84 | 89 | PF00244 | 0.427 |
LIG_FHA_1 | 35 | 41 | PF00498 | 0.435 |
LIG_FHA_2 | 27 | 33 | PF00498 | 0.490 |
LIG_FHA_2 | 50 | 56 | PF00498 | 0.435 |
LIG_FHA_2 | 70 | 76 | PF00498 | 0.345 |
LIG_LIR_Gen_1 | 75 | 83 | PF02991 | 0.457 |
LIG_LIR_Nem_3 | 75 | 80 | PF02991 | 0.457 |
LIG_SH2_CRK | 77 | 81 | PF00017 | 0.441 |
LIG_SH2_STAP1 | 77 | 81 | PF00017 | 0.498 |
LIG_SH2_STAT5 | 21 | 24 | PF00017 | 0.535 |
LIG_SUMO_SIM_par_1 | 39 | 45 | PF11976 | 0.535 |
MOD_CK1_1 | 34 | 40 | PF00069 | 0.516 |
MOD_CK1_1 | 42 | 48 | PF00069 | 0.469 |
MOD_CK1_1 | 87 | 93 | PF00069 | 0.431 |
MOD_CK1_1 | 95 | 101 | PF00069 | 0.455 |
MOD_CK2_1 | 49 | 55 | PF00069 | 0.431 |
MOD_CK2_1 | 69 | 75 | PF00069 | 0.345 |
MOD_GlcNHglycan | 7 | 10 | PF01048 | 0.631 |
MOD_GlcNHglycan | 94 | 97 | PF01048 | 0.465 |
MOD_GSK3_1 | 83 | 90 | PF00069 | 0.446 |
MOD_GSK3_1 | 92 | 99 | PF00069 | 0.387 |
MOD_N-GLC_1 | 112 | 117 | PF02516 | 0.616 |
MOD_N-GLC_1 | 26 | 31 | PF02516 | 0.184 |
MOD_PK_1 | 84 | 90 | PF00069 | 0.427 |
MOD_PKA_2 | 83 | 89 | PF00069 | 0.561 |
MOD_Plk_1 | 112 | 118 | PF00069 | 0.546 |
MOD_Plk_1 | 26 | 32 | PF00069 | 0.480 |
MOD_Plk_1 | 99 | 105 | PF00069 | 0.491 |
MOD_Plk_4 | 31 | 37 | PF00069 | 0.487 |
MOD_Plk_4 | 84 | 90 | PF00069 | 0.448 |
MOD_Plk_4 | 99 | 105 | PF00069 | 0.467 |
TRG_DiLeu_BaEn_1 | 14 | 19 | PF01217 | 0.453 |
TRG_ENDOCYTIC_2 | 77 | 80 | PF00928 | 0.442 |
TRG_ER_diArg_1 | 56 | 59 | PF00400 | 0.450 |
TRG_ER_diArg_1 | 62 | 64 | PF00400 | 0.433 |
TRG_NLS_MonoCore_2 | 60 | 65 | PF00514 | 0.456 |
TRG_NLS_MonoExtN_4 | 58 | 65 | PF00514 | 0.443 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6D6 | Leptomonas seymouri | 81% | 96% |
A0A0S4IPA9 | Bodo saltans | 39% | 100% |
A0A1X0P2Y8 | Trypanosomatidae | 54% | 100% |
A0A3S7X3R7 | Leishmania donovani | 94% | 100% |
A0A422P0R9 | Trypanosoma rangeli | 54% | 100% |
A4HIN4 | Leishmania braziliensis | 86% | 100% |
A4I5Y1 | Leishmania infantum | 95% | 100% |
C9ZRA7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 51% | 100% |
E9B174 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
V5BX96 | Trypanosoma cruzi | 54% | 100% |